Business
Why Did Suven Life Sciences' Q4 Net Loss Widen by Over 65%?
Suven Life Sciences faces a challenging financial landscape as its net loss for Q4 of FY25 skyrockets by over 65% due to dwindling revenue. What does this mean for the company's future? Find out more…